Follow
Nirakar Rajbhandari
Title
Cited by
Cited by
Year
A multiscale map of the stem cell state in pancreatic adenocarcinoma
NK Lytle, LP Ferguson, N Rajbhandari, K Gilroy, RG Fox, A Deshpande, ...
Cell 177 (3), 572-586. e22, 2019
1282019
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer
W Lin, N Rajbhandari, C Liu, K Sakamoto, Q Zhang, AA Triplett, SK Batra, ...
Cancer research 73 (6), 1821-1830, 2013
802013
A prevalence of thyroid dysfunction in Kathmandu University Hospital, Nepal
M Aryal, P Gyawali, N Rajbhandari, P Aryal, D Raj
Biomedical Research 21 (4), 2010
762010
Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers
N Rajbhandari, WC Lin, W Barbara, T Aleata, W Kay-Uwe.
Cell Reports 18 (9), 2243-2255, 2017
552017
Genomic and epigenomic landscaping defines new therapeutic targets for adenosquamous carcinoma of the pancreas
E Lenkiewicz, S Malasi, TL Hogenson, LF Flores, W Barham, WJ Phillips, ...
Cancer research 80 (20), 4324-4334, 2020
442020
Janus kinase 1 is essential for inflammatory cytokine signaling and mammary gland remodeling
K Sakamoto, BL Wehde, KH Yoo, T Kim, N Rajbhandari, HY Shin, ...
Molecular and cellular biology 36 (11), 1673-1690, 2016
362016
Cancer Cell Dormancy in Novel Mouse Models for Reversible Pancreatic Cancer: A Lingering Challenge in the Development of Targeted Therapies
L Wan-Chi, N Rajbhandari, KU Wagner
Cancer Research, 2014
342014
Microalbuminuria among type-2 diabetes mellitus patients in Pokhara, Nepal
M Sigdel, N Rajbhandari, S Basnet, A Nagila, P Basnet, T Basanta
Nepal Medical College Journal 10 (4), 242-245, 2008
302008
Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma
LP Ferguson, J Gatchalian, ML McDermott, M Nakamura, K Chambers, ...
Nature Communications 14 (1), 292, 2023
42023
Repurposing HDAC and mTOR inhibitors for pancreatic cancer.
M Biermann, C Quintero, P Ferguson, N Rajbhandari, DE Park, H Patel, ...
Journal of Clinical Oncology 40 (16_suppl), e16234-e16234, 2022
32022
Department of Biochemistry
M Aryal, P Gyawali, N Rajbhandari, P Aryal, DR Pandeya
Kathmandu University School of Medical Sciences/Dhulikhel Hospital-Kathmandu …, 2010
22010
Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancer
N Rajbhandari, M Hamilton, CM Quintero, LP Ferguson, R Fox, ...
Cancer cell 41 (11), 1989-2005. e9, 2023
12023
Abstract PR13: Single-cell mapping reveals a common origin for diverse subtypes of pancreatic cancer
N Rajbhandari, M Hamilton, T Reya
Cancer Research 84 (2_Supplement), PR13-PR13, 2024
2024
Tracing tumor evolution and subtype specification in pancreatic cancer
N Rajbhandari, M Hamilton, C Quintero, LP Ferguson, R Fox, CM Schurch, ...
2021
Abstract PO-036: Defining the role of chromatin remodelers in pancreatic cancer
LP Ferguson, J Gatchalian, N Lytle, N Rajbhandari, M McDermott, ...
Cancer Research 80 (22_Supplement), PO-036-PO-036, 2020
2020
Abstract PO-043: Interception of pancreatic cancer progression
ML McDermott, LP Ferguson, K Chambers, N Rajbhandari, T Reya
Cancer Research 80 (22_Supplement), PO-043-PO-043, 2020
2020
Abstract B18: Defining the role of chromatin remodeling complexes in pancreatic cancer stem cells
LP Ferguson, J Gatchalian, NK Lytle, N Rajbhandari, K Chambers, ...
Cancer Research 79 (24_Supplement), B18-B18, 2019
2019
Autocrine IGF1 signaling mediates the survival of pancreatic cancer cells following the ablation of oncogenes
N Rajbhandari
Cancer Research 77 (13_Supplement), 1848-1848, 2017
2017
Tumor cell dormancy is mediated by an increase in RTK signaling in reversible pancreatic cancer models expressing oncogenic K-Ras and c-Myc
N Rajbhandari
Cancer Research 76 (14_Supplement), 667-667, 2016
2016
The role of oncogenic KRAS in initiation, progression and maintenance of pancreatic cancer
N Rajbhandari
2016
The system can't perform the operation now. Try again later.
Articles 1–20